Dexcom Reports Fourth Quarter and Fiscal Year 2019 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- AMD shares fall amid AI chip sector selloff
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
DexCom (DXCM) Tops Q4 EPS by 41c, Revenues Beat; Offers FY20 Revenue Guidance
February 13, 2020 4:02 PM ESTDexCom (NASDAQ: DXCM) reported Q4 EPS of $1.15, $0.41 better than the analyst estimate of $0.74. Revenue for the quarter came in at $462.8 million versus the consensus estimate of $442.38 million.
Fourth Quarter 2019 Highlights:
Revenue grew 37% versus the same quarter of the prior year to $462.8... More


